Head-to-head · Cost-Efficiency Index
REMEVi vs Vivanta Care
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
REMEVi
Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.
Visit REMEViVivanta Care
People starting a GLP-1 at a low dose who want a cheap first few months and can see what the higher doses will cost before they sign up.
Visit Vivanta CareThe verdict
REMEVi and Vivanta Care tie on the Cost-Efficiency Index at 80/100, so neither wins outright on the numbers, so choose on fit. REMEVi: Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language. Vivanta Care: People starting a GLP-1 at a low dose who want a cheap first few months and can see what the higher doses will cost before they sign up.
Worth knowing either way: CoreAge Rx is one of our partners and leads our leaderboard, where partners are listed first (Cost-Efficiency Index 94/100). See how it stacks up: CoreAge Rx vs REMEVi.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | REMEVi | Vivanta Care |
|---|---|---|
| Cost-Efficiency Index | 80/100 | 80/100 |
| Semaglutide / mo | $219/mo | $79/moStarting dose; $169, $229 and $299 at higher dose stages, compounded |
| Tirzepatide / mo | $319/mo | $99/moStarting dose; $139, $249 and $329 at higher dose stages, compounded |
| Semaglutide / yr (modeled) | $2,628 | $948 |
| Tirzepatide / yr (modeled) | $3,828 | $1,188 |
| Coverage | All 50 states | All 50 states and D.C. |
| Oral / sublingual | Yes | No |
| Brand-name access | Compounded only | Compounded only |
| Rank here | #34 | #37 |
REMEVi
80/100Where the value is
- A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
- Longer terms are published openly rather than used as a teaser — semaglutide falls to $189 on 12 weeks and $149 on 52
- A daily oral semaglutide tablet is offered alongside the injection
The tradeoffs
- The flat rate is the highest entry price of the top-scoring programs here; the cheaper $149 figure needs a full year
- No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
Vivanta Care
80/100Where the value is
- All four dose-stage prices for each drug appear on the first screen of its quiz, before you answer any health questions
- Each plan covers the medical visit, the medication and shipping, with no separate membership fee
- Names its pharmacy (DiRx in Fort Lauderdale) and its clinician network (MD Integrations)
The tradeoffs
- The $79 and $99 prices cover only the starting dose; at the higher stages semaglutide reaches $299 and tirzepatide $329
- Its FAQ says pricing "stays the same at every dose", which doesn't match the dose-stage prices in the quiz
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.